表紙
市場調查報告書

全球製酸藥市場預測

Antacid Market 2019-2025

出版商 Orion Market Research Pvt Ltd 商品編碼 911648
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
全球製酸藥市場預測 Antacid Market 2019-2025
出版日期: 2019年08月28日內容資訊: 英文
簡介

本報告提供全球製酸藥市場的相關調查,提供市場機會,成長及阻礙因素,各藥物類別·製劑類型·地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 報告概要

  • 調查方法及工具
  • 市場分析

第2章 市場概要及洞察

  • 報告的範圍
  • 分析師的洞察及目前市場趨勢
  • 規則及法規

第3章 競爭情形

  • 企業佔有率分析
  • 主要策略分析
  • 主要企業分析
    • GlaxoSmithKline PLC
    • Bayer AG
    • Abbott Laboratories
    • Sanofi SA
    • Pfizer Inc.

第4章 市場決策要素

  • 成長要素
  • 阻礙因素
  • 市場機會

第5章 市場區隔

  • 各類藥物
    • H2拮抗劑
    • 質子幫浦抑制劑
    • 酸中和劑
  • 各製劑類別
    • 錠劑
    • 液體
    • 粉末

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 其他地區

第7章 企業簡介

  • Abbott Laboratories
  • AstraZeneca PLC
  • Bayer AG
  • Dabur India Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • First Aid Only, a company of Acme United Corp.
  • GCP Laboratories
  • GlaxoSmithKline PLC
  • Guardian Drug Company
  • Pfizer Inc.
  • Piramal Group
  • Reckitt Benckiser Group PLC
  • Sanofi SA
  • SPI Pharma
  • Sun Pharmaceuticals Industries Ltd.
  • 武田藥品工業株式會社
  • The Procter & Gamble Co.
  • WellSpring Pharmaceutical Corp.
目錄
Product Code: OMR2019866

Title:
Global Antacid
Market Size, Share & Trends Analysis Report by Drug Class (Proton Pump Inhibitor, H2 Antagonist, and Acid Neutralizers) and by Formulation Type (Tablet, Liquid, and Powder) and Forecast, 2019-2025.

The global antacid market is projected to register significant growth during the forecast period. Antacids are the class of drugs that are used to cure acid reflux that causes heartburns and acidity. The growth of the antacid market is expected to grow on the backdrop of the growing geriatric population suffering from gastroesophageal reflux disease (GERD). The widespread practice of self-medication among the population suffering from acidity and heartburns is a major factor propelling the market growth across the globe. Availability of antacids on various packaging formats such as ready-to-drink, sachet format, and many other formats serves the purpose of ease of use and increases the shelf-life of the product.

The antacid market is segmented on the basis of drug class and formulation type. Based on drug class, the market is segmented into a proton pump inhibitor, H2 antagonist, and acid neutralizers. Among these drug classes, the proton pump inhibitors are expected to register considerable growth in the market during the forecast period as the various proton pump inhibitors work for heartburns that are not resolved by acid neutralizers and h2 antagonist. Moreover, proton pump inhibitors the preferred solutions for consumers suffering from chronic heartburn. Based on formulation types, the market is segmented into tablet, liquid, and powder. Tablet segment is expected to register significant growth in the market during the forecast period, owing to the availability of chewing tablet in various flavors that adheres the consumers to medication. Moreover, tablets offer the right amount of dosage as compared to other types of formulation.

Geographically, the global antacid market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America holds a significant share in the global antacid market, owing to the rising prevalence of the digestive disease in the region. A sedentary lifestyle coupled with unhealthy dietary habits and less of physical activity are some of the key factors pointed towards the rising gastric diseases in the region, which in turn, increases the adoption rate of antacids in North America.

The major players operating in the global antacid market include GlaxoSmithKline PLC, Abbott Laboratories, Reckitt Benckiser Group PLC, Bayer AG, Sanofi SA, Pfizer Inc., and The Procter & Gamble Co. to outreach the customer base, many companies are adopting the strategies of acquisitions, mergers, and product launch. For instance, in April 2017, Piramal Enterprises has launched the 'Paan' flavored 'Polycrol', the company's antacid brand. The polycrol offers the consumer a pleasant after-taste while offering relief from acidity.

Research Methodology

The market study of the global antacid market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for healthcare and pharmaceuticals providers for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • 1. Global Antacid Market Research and Analysis by Drug Class
  • 2. Global Antacid Market Research and Analysis by Formulation Type

The Report Covers:

  • Comprehensive research methodology of the global antacid market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global antacid market.
  • Insights about market determinants which are stimulating the global antacid market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. GlaxoSmithKline PLC
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Bayer AG
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Abbott Laboratories
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Sanofi SA
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Pfizer Inc.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Antacid Market by Drug Class
    • 5.1.1. H2 Antagonist
    • 5.1.2. Proton Pump Inhibitors
    • 5.1.3. Acid Neutralizers
  • 5.2. Global Antacid Market by Formulation Type
    • 5.2.1. Tablet
    • 5.2.2. Liquid
    • 5.2.3. Powder

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories
  • 7.2. AstraZeneca PLC
  • 7.3. Bayer AG
  • 7.4. Dabur India Ltd.
  • 7.5. Dr. Reddy's Laboratories Ltd.
  • 7.6. First Aid Only, a company of Acme United Corp.
  • 7.7. GCP Laboratories
  • 7.8. GlaxoSmithKline PLC
  • 7.9. Guardian Drug Company
  • 7.10. Pfizer Inc.
  • 7.11. Piramal Group
  • 7.12. Reckitt Benckiser Group PLC
  • 7.13. Sanofi SA
  • 7.14. SPI Pharma
  • 7.15. Sun Pharmaceuticals Industries Ltd.
  • 7.16. Takeda Pharmaceutical Co. Ltd.
  • 7.17. The Procter & Gamble Co.
  • 7.18. WellSpring Pharmaceutical Corp.

List of Tables

  • 1.GLOBAL ANTACID MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2018-2025 ($ MILLION)
  • 2. GLOBAL H2 ANTAGONIST MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL ACID NEUTRALIZERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBAL ANTACID MARKET RESEARCH AND ANALYSIS BY FORMULATION TYPE, 2018-2025 ($ MILLION)
  • 6. GLOBAL TABLET MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 7. GLOBAL LIQUID MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 8. GLOBAL POWDER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 9. GLOBAL ANTACID MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 10. NORTH AMERICAN ANTACID MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 11. NORTH AMERICAN ANTACID MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2018-2025 ($ MILLION)
  • 12. NORTH AMERICAN ANTACID MARKET RESEARCH AND ANALYSIS BY FORMULATION TYPE, 2018-2025 ($ MILLION)
  • 13. EUROPEAN ANTACID MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 14. EUROPEAN ANTACID MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2018-2025 ($ MILLION)
  • 15. EUROPEAN ANTACID MARKET RESEARCH AND ANALYSIS BY FORMULATION TYPE, 2018-2025 ($ MILLION)
  • 16. ASIA-PACIFIC ANTACID MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 17. ASIA-PACIFIC ANTACID MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2018-2025 ($ MILLION)
  • 18. ASIA-PACIFIC ANTACID MARKET RESEARCH AND ANALYSIS BY FORMULATION TYPE, 2018-2025 ($ MILLION)
  • 19. REST OF THE WORLD ANTACID MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2018-2025 ($ MILLION)
  • 20. REST OF THE WORLD ANTACID MARKET RESEARCH AND ANALYSIS BY FORMULATION TYPE, 2018-2025 ($ MILLION)

List of Figures

  • 1. GLOBAL ANTACID MARKET SHARE BY DRUG CLASS, 2018 VS 2025 (%)
  • 2. GLOBAL ANTACID MARKET SHARE BY FORMULATION TYPE, 2018 VS 2025 (%)
  • 3. GLOBAL ANTACID MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 4. US ANTACID MARKET SIZE, 2018-2025 ($ MILLION)
  • 5. CANADA ANTACID MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. UK ANTACID MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. FRANCE ANTACID MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. GERMANY ANTACID MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. ITALY ANTACID MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. SPAIN ANTACID MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. REST OF EUROPE ANTACID MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. INDIA ANTACID MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. CHINA ANTACID MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. JAPAN ANTACID MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC ANTACID MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF THE WORLD ANTACID MARKET SIZE, 2018-2025 ($ MILLION)